Director
Solid Tumor Cellular Immunotherapy Program, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA., United States
58: Uveal Melanoma Immunogenomics Predict Immunotherapy Resistance and Susceptibility
Friday, March 22, 2024
1:50pm – 2:02pm ET